Organon (OGN) Misses Q4 EPS by 13c; offers guidance

Organon (NYSE: OGN) reported Q4 EPS of $0.63, $0.13 worse than the analyst estimate of $0.76. Revenue for the quarter came in at $1.51 billion versus the consensus estimate of $1.54 billion.

GUIDANCE:

Organon sees FY2026 revenue of $6.2 billion, versus the consensus of $6.111 billion.

For earnings history and earnings-related data on Organon (OGN) click here.

You May Also Be Interested In

• S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
• ICICI Securities Reiterates Buy (1) Rating on Hindustan Unilever Ltd (HUVR:IN)
• ADARx Pharmaceuticals files for proposed IPO